Processing of proaugurin is required to suppress proliferation of tumor cell lines.
about
Esophageal cancer-related gene 4 at the interface of injury, inflammation, infection, and malignancyEsophageal cancer related gene-4 is a choroid plexus-derived injury response gene: evidence for a biphasic response in early and late brain injury.Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer.Ecrg4 attenuates the inflammatory proliferative response of mucosal epithelial cells to infectionEsophageal cancer-related gene-4 (ECRG4) interactions with the innate immunity receptor complex.Thrombin-processed Ecrg4 recruits myeloid cells and induces antitumorigenic inflammationECRG4 expression in normal rat tissues: expression study and literature reviewCell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages.Pulmonary preconditioning, injury, and inflammation modulate expression of the candidate tumor suppressor gene ECRG4 in lung.Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4The candidate tumor suppressor gene Ecrg4 as a wound terminating factor in cutaneous injuryp-Hydroxylcinnamaldehyde induces the differentiation of oesophageal carcinoma cells via the cAMP-RhoA-MAPK signalling pathway.C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes.Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition.ZNF580 mediates eNOS expression and endothelial cell migration/proliferation via the TGF-β1/ALK5/Smad2 pathway.Overexpression of ECRG4 enhances chemosensitivity to 5-fluorouracil in the human gastric cancer SGC-7901 cell line.A short synthetic peptide fragment of human C2ORF40 has therapeutic potential in breast cancer.Ecrg4 contributes to the anti-glioma immunosurveillance through type-I interferon signalingEcrg4 peptide is the ligand of multiple scavenger receptors.
P2860
Q28652488-687F9E39-9118-430F-9820-F73572C05997Q34026189-7D46F110-0B46-47D0-AA50-265C9D2B1A46Q34081686-802EDAA3-7F5D-4F73-9845-426602C3BE79Q34692113-D81013E3-4089-4542-8916-C506042C8E1CQ34995542-D600AA11-D787-4FC6-B194-BD1B5AFA178AQ35788583-DB44CE25-40A0-4231-926F-92B755BCF0F6Q35856436-8033D77F-88A9-40A6-AB5D-1E37B0DF3BD5Q35912993-12A541A7-8410-450E-832C-0F1D8D309928Q35915188-9E1C85D8-6FDD-4474-B69B-517E5FB5B2DFQ36007789-4AB2EDDE-DF65-4089-B53F-56428D1231D6Q36434553-0159FA86-A9A0-4794-BF69-15B67CEB4CA1Q37159947-C5435903-9DDA-4C30-A95F-D38BF311B4A6Q37378652-B581BF5D-19C6-4CD8-98DB-9AB025812DCAQ38514648-692B5346-FCC5-43D6-AC90-DC6E53445AB4Q39000890-55A6D6AA-AE89-4B90-8BF9-7B6384668335Q39172036-89DEF44F-EE4C-4EA7-BF04-4A18847A4CDEQ41091827-D05E97F5-3725-4317-B452-5DB49B9B8538Q42180788-42D84213-72FC-46B2-8943-75E1C7439661Q52728417-0F50B87C-CFED-47F2-8F03-842E40E7A471
P2860
Processing of proaugurin is required to suppress proliferation of tumor cell lines.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Processing of proaugurin is required to suppress proliferation of tumor cell lines.
@ast
Processing of proaugurin is required to suppress proliferation of tumor cell lines.
@en
type
label
Processing of proaugurin is required to suppress proliferation of tumor cell lines.
@ast
Processing of proaugurin is required to suppress proliferation of tumor cell lines.
@en
prefLabel
Processing of proaugurin is required to suppress proliferation of tumor cell lines.
@ast
Processing of proaugurin is required to suppress proliferation of tumor cell lines.
@en
P2093
P2860
P356
P1476
Processing of proaugurin is required to suppress proliferation of tumor cell lines.
@en
P2093
Adam N Lick
Akihiko Ozawa
Iris Lindberg
P2860
P304
P356
10.1210/ME.2010-0389
P577
2011-03-24T00:00:00Z